{"id":"W4403303293","doi":"10.1016/j.kint.2024.09.012","title":"Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum","year":2024,"lang":"en","type":"article","venue":"Kidney International","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Medical Research Council; National Institutes of Health; Idorsia Pharmaceuticals; Samsung; Akershus Universitetssykehus; Swedish Orphan Biovitrum; Apellis Pharmaceuticals; Omeros Corporation; Therakos; BioCryst; Alnylam Pharmaceuticals; Alexion Pharmaceuticals; Sanofi; GlaxoSmithKline; Bristol-Myers Squibb; AstraZeneca; Pfizer","keywords":"Nephrology; Medicine; Internal medicine; Haemolytic-uraemic syndrome; Intensive care medicine; Chemistry; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.000231266,0.0002296604,0.0002534028,0.0001287953,0.00008787429,0.00009070713,0.001557434,0.0001488126,0.01536633],"category_scores_gemma":[0.0002814966,0.000170532,0.0004306479,0.00009171971,0.0002446493,0.0002212314,0.0005015075,0.0002831782,0.0007926908],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002050682,"about_ca_system_score_gemma":0.0002439746,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003209656,"about_ca_topic_score_gemma":0.000026321,"domain_scores_codex":[0.998427,0.00006584806,0.0005809796,0.0004265124,0.000241263,0.0002583686],"domain_scores_gemma":[0.9986035,0.0006917934,0.000168256,0.0003207177,0.0001736025,0.00004216986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006208333,0.0001139417,0.09886388,0.0000127346,0.003826043,0.000007205446,0.0003547748,0.000008195095,0.03403059,0.008085947,0.8535109,0.001123736],"study_design_scores_gemma":[0.001254426,0.00003126797,0.04366037,0.0001881045,0.000106321,0.0001048573,0.0005424042,0.001055545,0.00306083,0.002852362,0.946933,0.0002104985],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5261415,0.00366708,0.00230096,0.3751539,0.05927507,0.0008914606,0.0110562,0.0005553648,0.02095853],"genre_scores_gemma":[0.9824167,0.00008585445,0.0003159216,0.008150854,0.0003533787,0.00006804868,0.002780175,0.00002541471,0.005803673],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4562753,"threshold_uncertainty_score":0.9999853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02127626511417251,"score_gpt":0.2802181711337426,"score_spread":0.2589419060195701,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}